Stephanie Casey Parks, PhDCancer Pharmacology Leader at IndependentSpeaker
Profile
Stephanie Casey Parks, Ph.D., is an oncology pharmacology leader with extensive experience in preclinical drug development. She most recently served as a Senior Principal Scientist and group leader at Amgen in Oncology Research. She has led in vivo research across diverse therapeutic modalities, including antibodies, antibody-drug conjugates, and T cell engagers. Her work has focused on characterizing emerging targets, evaluating pharmacodynamic and efficacy responses to novel therapeutics, and developing innovative preclinical models. She earned her B.S. from UCLA and Ph.D. in Cancer Biology from UC Irvine, followed by postdoctoral training at Stanford where she utilized mouse models to study oncogenes.
Agenda Sessions
Co-Chairs' Remarks: From Discovery to IND: What Matters Most and How to Get it Right
, 1:00pmView SessionModerated Panel Discussion with Session Speakers
, 4:15pmView Session
